Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 3.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 42,482 shares of the company’s stock after purchasing an additional 1,591 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in HCA Healthcare were worth $16,275,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its holdings in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after buying an additional 587,036 shares in the last quarter. Nuveen LLC acquired a new position in shares of HCA Healthcare in the first quarter worth $569,217,000. Pacer Advisors Inc. boosted its stake in shares of HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the last quarter. Finally, Nordea Investment Management AB lifted its holdings in HCA Healthcare by 6.8% in the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after purchasing an additional 59,163 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
HCA has been the subject of a number of analyst reports. TD Cowen boosted their price objective on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Barclays increased their price target on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Truist Financial upped their target price on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Finally, Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $474.53.
HCA Healthcare Price Performance
NYSE HCA opened at $472.40 on Friday. The business’s 50-day simple moving average is $433.56 and its 200-day simple moving average is $396.45. The firm has a market capitalization of $107.80 billion, a P/E ratio of 18.26, a P/E/G ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $480.00.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the previous year, the company posted $4.90 earnings per share. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.
Insider Buying and Selling at HCA Healthcare
In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by corporate insiders.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- Trading Stocks: RSI and Why it’s Useful
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- How to Short a Stock in 5 Easy Steps
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
